Have a personal or library account? Click to login
Review: monoclonal reagents and detection of unusual or rare phenotypes or antibodies Cover

Review: monoclonal reagents and detection of unusual or rare phenotypes or antibodies

By: M.K. Moulds  
Paid access
|Apr 2020

References

  1. Stroup M. A review: the use of monoclonal antibodies in blood banking. Immunohematol 1990;6:30-6.10.21307/immunohematology-2019-1037
  2. Case J. Monoclonal technology. Paper presented at:“What’s New”Workshop at: Annual meeting of the South Central Association of Blood Banks, 1992.
  3. Case J. Monoclonal antibodies in blood bank reagents. Paper presented at: Annual meeting of the Pennsylvania Association of Blood Banks, 1993.
  4. Case J. Blood groups. Short topic. Monoclonal/ polyclonal reagents. Some practical differences in performance. Paper presented at: the Sally Frank Lecture at AABB, 1998.
  5. Olsson ML, Irshaid, NM, Hosseini-Maaf B, et al. Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: identification of 15 novel A and B subgroup alleles. Blood 2001;98:1585-93.10.1182/blood.V98.5.1585
  6. Moore S, Chirnside A, Micklem LR, McClelland DB, James K. A mouse monoclonal antibody with anti-A,(B) specificity which agglutinates Ax cells. Vox Sang 1984;47:427-34.10.1111/j.1423-0410.1984.tb03879.x6516295
  7. McGowan A, Tod A, Chirnside A, et al. Stability of murine monoclonal anti-A, anti-B and anti-A, B ABO grouping reagents and a multi-centre evaluation of their performance in routine use. Vox Sang 1989;56:122-30.10.1111/j.1423-0410.1989.tb04964.x2665316
  8. Rumsey DM, Armour R, Nester TA. Serologic and genomic analysis of three blood donors with ABO anomalies (abstract). Transfusion 2003;43(Suppl) 94A.
  9. Yamamoto F, McNeill PD, Yamamoto M, et al. Molecular genetic analysis of the ABO blood group system: 3, A(x) and B(A) alleles. Vox Sang 1993:64:171-4.10.1111/j.1423-0410.1993.tb05157.x8484250
  10. Beck ML, Hardman JT, Henry R. Reactivity of a licensed murine monoclonal anti-A reagent with group B cells (abstract). Transfusion 1986;26 (Suppl):572.
  11. Beck ML, Yates AD, Hardman J and Kowalski MA. Identification of a subset of group B donors reactive with monoclonal anti-A reagents. Am J Clin Pathol 1989;29:625-9.10.1093/ajcp/92.5.6252510496
  12. Beck M and Kowalski M. Unexpected activity with monoclonal anti-B reagents. (Communication) Immunohematol 1992;8:22.
  13. Beck ML, Korth J, Judd J. High incidence of acquired-B detectable by monoclonal anti-B reagents (abstract). Transfusion 1992;32(Suppl): 17S.
  14. Pedreira PP, Noto TA. Detection of acquired B phenomenon with monoclonal reagents (abstract). Transfusion 1992;32(Suppl):17S.
  15. Stratton F. A new Rh allelomorph. Nature 1946; 158:25.10.1038/158025c021064942
  16. Moore BPL. Does knowledge of Du status serve a useful purpose? Vox Sang 1984;46(Suppl):95-7.10.1111/j.1423-0410.1984.tb00134.x
  17. Agre PC, Davies DM, Issitt PD, et al. A proposal to standardize terminology for weak D antigen (Letter to Editor). Transfusion 1992;32:86-7.10.1046/j.1537-2995.1992.32192116441.x1731444
  18. Standards for blood banks and transfusion services. 23rd ed. Bethesda, MD: AABB, 2004: 5.13.2;38.
  19. Jones J, Filbey D. Selection of monoclonal antibodies for the identification of D variants: ability to detect weak D and to split epD2, epD5 and ep D6/.7. Vox Sang 1996;70:17309.
  20. Wagner FF, Gossner C, Muller TH, Schonitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385-93.10.1182/blood.V93.1.385
  21. Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005;45:1554-60.10.1111/j.1537-2995.2005.00586.x16181204
  22. Jenkins CM, Johnson ST, Bellissimo DB, Gottschall JL. Incidence of weak D in blood donors typed Rh positive by Olympus PK7200. Immunohematol 2005;21:152-4.10.21307/immunohematology-2019-411
  23. Tippett P, Lomas-Francis, Wallace M. The Rh antigen D: partial D antigens and associated low incidence antigens. Vox Sang 1996;70:123-31.10.1111/j.1423-0410.1996.tb01309.x8740002
  24. Judd WJ, Moulds M, Schlanser G. Reactivity of FDA-approved monoclonal anti-D reagents with partial D RBCs. Immunohematol 2005;21:146-8.10.21307/immunohematology-2019-409
  25. Wallace M, Lomas-Francis C, Tippett P. The D antigen characteristic of RoHar is a partial D antigen. Vox Sang 1996;70:169-72.
  26. Beckers EAM, Porcelun L, Ligthart H, et al. The RoHar antigenic complex is associated with a limited number of D epitopes and alloanti-D production: a study of three unrelated persons and their families. Transfusion 1996;36:104-8.10.1046/j.1537-2995.1996.36296181919.x8614957
  27. Hazenberg C. Hemolytic disease of the newborn caused by alloanti-D from an RoHar Rh:33 mother (Letter to Editor). Transfusion 1996;36:478-9.10.1046/j.1537-2995.1996.36596282599.x8693521
  28. Schlanser G, Ligthart P, Overbeeke M, Davis J, Poole J. First report in North America of alloanti-D in a RoHar individual (abstract). Transfusion 2001;41 (Suppl):105S.
  29. Beckers EA, Fass BH, von dem Borne AE, et al. The RoHar phenotype results from substitution of exon 5 of the RHCE gene by the corresponding exon of the RH D gene. Br J Haematol 1996; 92:751.10.1046/j.1365-2141.1996.382918.x8616049
  30. Cobb ML. Crawford: Investigation of a new low frequency red cell antigen (abstract). Transfusion 1980;30:631.
  31. Moulds MK, Schlanser, Frame T, Adamson CN, MacNeill S. Reactivity of monoclonal anti-D reagents with 27 samples shown to have the Crawford (Rh43) low-incidence antigen and/or a novel RHCE variant Rhce allele (abstract). Transfusion 2003;43(Suppl):7A.
  32. Flegel WA, Wagner FF, Chen Q, Schlanser G, Frame T, Westhoff C, Moulds MK. The RHCE allele of ceCF: the molecular basis of Crawford (RH43). Transfusion 2006: in press.10.1111/j.1537-2995.2006.00901.x16934069
  33. Esteban R, Nougues N, Montero R, et al; RhD epitope expression in a RHD negative individual. Characterization of a novel RHce variant allele (abstract). Clin Biol (Suppl 1) 2001;8:8s.
  34. Rikabi N, Krugh DW, Kennedy M. Rh (D) typing discrepancy similar to RoHAR. Transfusion 2003; 43(Suppl):96A.
  35. Westhoff CM, Vege S, Nance S, Frame T, Moulds MK. Determination of the molecular background of the Crawford antigen occurring with a weak C antigen (abstract). Vox Sang 2004;87(Suppl 3): S17-S92.
  36. Slayten JK, Larimore KS, Jansson KA, Lintner MK, Willig SM, Hupp JL. Management of RH43 positive donor (abstract). Transfusion 2004;44(Suppl): 115A.10.1111/j.0041-1132.2004.449_2.x
  37. Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego CA, Academic Press, 2004:152.10.1016/B978-012586585-2/50007-X
  38. Faas BH, Beckers EA, Wildoer P, et al. Molecular background of VS and weak C expression in blacks. Transfusion 1997;37(1):38-44.10.1046/j.1537-2995.1997.37197176949.x9024488
  39. Daniels GL, Faas BH, Green CA, et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion 1998;38:951-8.10.1046/j.1537-2995.1998.381098440860.x9767746
  40. Rosenfield RE, Haber GV, Schroeder R, Ballard R. Problems in Rh typing as revealed by a single Negro family. Am J Hum Genet 1960;12:147-59.
  41. Daniels G. Human blood groups. 2nd ed. Blackwell Science, Oxford. 2002:232-3, 2430-4.
  42. Greenwalt TJ, Sanger R. The Rh antigen Ew. Br J Haematol 1955;1:52-4.10.1111/j.1365-2141.1955.tb05487.x13239995
  43. Lubenko A, Burslem SJ, Fairclough LM, Pope J, Boyd D, Bacon J. A new qualitative variant of the RhE antigen revealed by heterogeneity among Anti-E sera. Vox Sang 1991;60:235-40.10.1111/j.1423-0410.1991.tb00912.x1718091
  44. Noizat-Pirenne F, Mouro I, Gane P, et al. Molecular basis of qualitative RhE variants (abstract). Vox Sang 1991;74(Suppl 1):54.
  45. Noizat-Pirenne F, Mouro I, Le Pennec P, Verdier M, Babinet J, Jusczak G, Rouger P, Cartron J. Molecular basis of category EIV variant phenotype (abstract). Transfusion 1999;39(Suppl):103S.
  46. Kashiwase K, Ishikawa Y, Hyodo H, et al. E variants found in Japanese and c antigenicity alteration without substitution in the second extracellular loop. Transfusion 2001;41:1408-12.10.1046/j.1537-2995.2001.41111408.x11724987
  47. Huestis DW, Catino ML, Busch S. A “new” Rh antibody (anti-Rh-26) which detects a factor usually accompanying hr′. Transfusion 1964;4: 414-8.10.1111/j.1537-2995.1964.tb02900.x14242756
  48. Moulds JJ, Case J, Anderson TD, Cooper ED. The first example of allo-anti-c produced by a c-positive individual (abstract). Transfusion 1982; 289: Th-100.
  49. Faas BHW, Ligthart PC, Lomas-Francis C, Overbeeke MAM, von dem Borne AEGKr, van der Schoot CE. Involvement of Gly96 in the formation of the Rh26 epitope. Transfusion 1997;37: 1123-30.10.1046/j.1537-2995.1997.37111298088040.x9426634
  50. Kemper M, Sazama K. New human monoclonal antibody reagents for detecting C, c, E, e, K1, Jka and Jkb red cell antigens. Immunohematol 1994; 10:8-11.10.21307/immunohematology-2019-811
  51. Issitt PD. An invited review: the Rh antigen e, its variants, and some closely related serological observations. Immunohematol 1991;7:29-36.10.21307/immunohematology-2019-1007
  52. Blancher AP, Reid ME, Alie-Daram SJ, Dugoujon J-MH, Roubinet EL. Characterization of human anti-hrB-like monoclonal antibody. Immunohematol 1996;12:119-22.10.21307/immunohematology-2019-762
  53. Reid ME, Storry JR, Issitt PD, et al. Rh haplotypes that make e but not hrB usually make VS. Vox Sang 1997;42:41-4.10.1159/000461956
  54. Skradski K,. Reid ME, Mount M, et al. A novel variant of the human blood group K1 antigen. Vox Sang 1994;66:68-71.10.1111/j.1423-0410.1994.tb00280.x8146986
  55. Poole J, Hustinx, Warke N, Crew V, Martin P, Daniels G. A new K allele of the KEL gene. Transfus Med 2002;12:4.
  56. Daniels G. Human blood groups (ibid Ref 40):116, 137-8.
  57. Henry S, Mollicone R, Fernandez P, Samuelsson B, Oriol R, Larson G. Molecular basis for erythrocyte Le(a+b+) and the salivary ABH partial-secretor phenotypes. Expression of a FUT2 secretor allele with an A to T mutation at nucleotide 385 correlates with reduced α (1,2) fucosyltransferase activity. Glycoconj J 1996:13:985-93.10.1007/BF010531948981090
  58. Brendemoen OJ. Some factors influencing Rh immunization during pregnancy. Acta Path Microbiol Scan 1952;31:579-83.10.1111/j.1699-0463.1952.tb00225.x
  59. Henry S. Review: phenotyping for Lewis and secretor histo-blood group antigens. Immunohematol 1996;12:51-61.10.21307/immunohematology-2019-746
  60. Chester MA, Johnson U, Lundblad A, et al, eds. Proc 2nd Int workshop and symposium on monoclonal antibodies against human red blood cells and related antigens 1990:86-92.
  61. Beck ML, ed. Third international workshop on monoclonal antibodies against human red blood cell and related antigens. Transfus Clin Biol 1997;4:13-54 (8 papers).
  62. Moulds MK, Spruell P, Lomas C, et al. Experience in the use of a monoclonal polyspecific anti-human globulin reagent for antibody investigation. Vox Sang 1994;67: S2:121.
  63. Bell JA, Johnson ST. Reactivity of “high titer, low avidity” antibodies using murine monoclonal anti-IgG and polyethylene glycol (abstract). Transfusion 1994;34(Suppl):18S.
  64. Moulds JM, Masouredis SP, eds. Monoclonal antibodies. Arlington VA. American Association of Blood Banks, 1989.
  65. Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham NC: Montgomery Scientific Publications, 1998.
  66. Westhoff C. The Rh blood group system in review: A new face for the next decade. Transfusion 2004;44:1663-73.10.1111/j.0041-1132.2004.04237.x15504174
  67. Westhoff C. Review: the Rh blood group D antigen…dominant, diverse and difficult. Immunohematol 2005;21:155-63.10.21307/immunohematology-2019-412
  68. Moulds MK. Monoclonal antibodies as blood bank reagents. Advance for Administrators of the Laboratory 2004;13:16-22.
DOI: https://doi.org/10.21307/immunohematology-2019-347 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 52 - 63
Published on: Apr 13, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 M.K. Moulds, published by American National Red Cross
This work is licensed under the Creative Commons License.